VIT vitura health limited

Ann: Trading Halt, page-3

  1. 901 Posts.
    lightbulb Created with Sketch. 380
    I did just wrap up watching this.

    At 2 points Cortexa was brought up
    @4:10 Will Avery mentions that during Q1 they didn't ship product to patents under the SAP or to clinical trials and revenue was limited to the Cortexa license fees.
    @18:44 A question point blank around any upcoming news with Cortexa Nick Kadysh shuts the question down quick.

    Side note, they spend a decent portion of the Webinar talking about finding non dilutive funding to progress their own clinical trials goals.

    Just a hypothesis for the moment.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
7.1¢
Change
-0.003(4.05%)
Mkt cap ! $47.02M
Open High Low Value Volume
7.4¢ 7.4¢ 7.1¢ $10.85K 149.0K

Buyers (Bids)

No. Vol. Price($)
1 82 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 20939 1
View Market Depth
Last trade - 15.01pm 07/08/2025 (20 minute delay) ?
VIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.